Metraipolis › archive › dc_7ffe628f7496

Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a… — Europe PMC PMID:40900328

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40900328
DOI
10.1007/s00345-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-10T03:27:56.860Z
SHA-256 of the archived text
fb065412d2829dae614aef77b043c6d538cedb2b56ac7d09a56c7be9b9df403c
Stable URL of this page
https://metraipolis.com/documento/dc_7ffe628f7496

How to cite

Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a… — Europe PMC PMID:40900328 — Europe PMC (en), https://europepmc.org/article/MED/40900328 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ffe628f7496 (Metraipolis archive dc_7ffe628f7496, sha256 fb065412d2829dae614aef77b043c6d538cedb2b56ac7d09a56c7be9b9df403c)
BibTeX
@misc{dc7ffe628f7496,
  title = {Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a… — Europe PMC PMID:40900328},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40900328},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ffe628f7496; sha256 fb065412d2829dae614aef77b043c6d538cedb2b56ac7d09a56c7be9b9df403c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40900328. Agents can read the archived copy with the MCP tool read_document.